Home › Breast Carcinoma In Situ › Michigan
Breast Carcinoma In Situ clinical trials in Michigan
4 studies for Breast Carcinoma In Situ are looking for participants at sites in Michigan.
Cities in Michigan
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
- University of Michigan Rogel Cancer Center, Ann Arbor
RecruitingPhase 2Healthy volunteers welcome
Ages 45 to 74 · Women · Updated Aug 4, 2026 · NCT06195306Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
- University of Michigan Rogel Cancer Center, Ann Arbor
RecruitingPhase 2
Ages 18 to 55 · Women · Updated Jul 27, 2026 · NCT06184750A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial
- University of Michigan Rogel Cancer Center, Ann Arbor
RecruitingPhase 2Healthy volunteers welcome
All ages · All sexes · Updated Apr 24, 2026 · NCT07443943The PREDICT Registry:
- Corewell Health William Beaumont University Center, Royal Oak
- Comprehensive Breast Care, Troy
RecruitingObservational study
Ages 30 to 85 · Women · Updated Apr 17, 2026 · NCT03448926From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.